Health

  • April 09, 2026

    Pest Co. Can't Eradicate Workers' Suit Over Tobacco Fees

    Pest control company Rentokil can't escape a proposed class action alleging it unlawfully charged tobacco users more for health benefits without providing a reasonable way to avoid the fee, with a Pennsylvania federal judge rejecting the company's argument that decade-old regulations were invalid.

  • April 09, 2026

    Kirkland-Led Court Square Capital Raises $3.8B

    Kirkland & Ellis LLP-advised private equity shop Court Square Capital Partners on Thursday announced that it wrapped its fifth fund with roughly $3.8 billion of capital commitments, marking the firm's largest fundraise to date.

  • April 09, 2026

    Philly Injection Site Row Judge Rejects Nonprofit's 'Ploy'

    A Pennsylvania federal judge on Thursday called the addition of overdose prevention nonprofit Safehouse's president as a counterclaim plaintiff in the government's suit to stop it from launching a safe-injection site in Philadelphia a "ploy" to add another to the ranks of those claiming the government infringed the group's religious freedom.

  • April 09, 2026

    Ex-Pharmacy Director Denies Using Trade Secrets At New Job

    A former director at a specialty infusion therapy pharmacy urged a New Jersey federal court to reject her former employer's bid to block her from working for a rival, arguing that her new job does not pose any threat of imminent harm to her former company.

  • April 09, 2026

    Feds Cast Calif. Tribe's Opioid Clinic Fight As Money Grab

    The federal government says it had justification for rejecting a California tribe's request for an agreement to fund an opioid treatment center, claiming that a challenge over the denial is more about trying to monetize on advantages available to Indigenous nations and less about helping patients.

  • April 09, 2026

    Colo. Co. Failed To Prevent Patient Data Leak, Suit Says

    A Colorado-based digital health company focused on reversing Type 2 diabetes is facing a proposed class action in federal court alleging it did not protect patients' personal and medical information from a cyberattack in late March that exposed their information to the dark web.

  • April 09, 2026

    Elevance Nurses' Federal OT Suit Sent From NC To Va.

    A class and collective action accusing insurer Elevance Health of misclassifying its nurses as overtime-exempt has been transferred from North Carolina to Virginia federal court, where the company faces related claims.

  • April 09, 2026

    US Again Urges High Court To Back Drug Price Program

    The administration of President Donald Trump again urged the Supreme Court not to hear a challenge to the Medicare drug price negotiation program, arguing against a constitutional challenge brought by Boehringer Ingelheim that drug companies aren't forced to accept lower prices because they can choose not to participate. 

  • April 08, 2026

    Ed. Dept. Says It's Not Required To Fund $1B In Youth Grants

    The U.S. Department of Education denied accusations by 16 U.S. states that it is flouting a court order to restore nearly $1 billion in K–12 mental health grants, arguing in a Western District of Washington filing that the order required officials to re-review the grants, not actually provide full funding.

  • April 08, 2026

    Va. Hospital Patient Seeks Final Nod For $3.1M Privacy Deal

    An Inova Health Care Services patient is urging a Virginia federal judge to grant final approval to a $3.1 million deal to resolve claims the healthcare system unlawfully shared private health information with Meta and Google through online tracking tools, arguing the resolution has received "overwhelming support" from the settlement class.

  • April 08, 2026

    Fla. Insurer, Ex-Parent To Pay $135M Over ACA Fraud Scheme

    A Florida insurer and its former parent, which is a Delaware-based national partnership of insurance brokers, have agreed to pay $135 million collectively to resolve allegations of a scheme to enroll ineligible consumers into subsidized Affordable Care Act plans and of defrauding the federal government of more than $140 million. 

  • April 08, 2026

    Biz Judge Keeps Doc Class Action Against Luxottica, For Now

    A Texas Business Court judge Wednesday kept alive, on procedural grounds, a proposed class action made up of Texas optometrists who say that their office space deals with eye care giant Luxottica of America Inc. didn't follow Texas law.

  • April 08, 2026

    AbbVie Says 340B Program Defines 'Patient' Too Broadly

    Federally funded healthcare providers in the 340B Drug Pricing Program are using an "overly broad" interpretation of the word "patient" based on government guidelines, and it's leading to them abusing 340B discounts, AbbVie claimed in a lawsuit filed against two federal health agencies Wednesday.

  • April 08, 2026

    No Surprises Act Bars Provider's Award Enforcement Bid

    A Pennsylvania federal court declined to force an insurer to pay over $300,000 in alleged outstanding payments from an out-of-network billing dispute with a provider, finding it lacked authority to do so under the No Surprises Act.

  • April 08, 2026

    States Seek Time For Talks To Settle Drug Price-Fixing Suit

    The states suing generic-drug manufacturers in one of three sprawling antitrust cases want a Connecticut federal judge to pause all deadlines for three months so they can focus on settling with the remaining defendants, according to a joint filing.

  • April 08, 2026

    3M Settles Ex-Worker's COVID Vax Firing Suit

    A former 3M Co. employee who claimed the company's COVID-19 vaccination mandate policy was "unnecessary" and "draconian" has settled his more than 3-year-old suit over his firing, according to a court filing.

  • April 08, 2026

    Lost Data Should Get Co. Punished In EEOC Suit, Judge Says

    A Georgia federal judge recommended sanctions against a cosmetic surgery provider for neglecting to keep sales data and messages, saying the information could've been relevant in a disability bias suit the U.S. Equal Employment Opportunity Commission brought on a former worker's behalf.

  • April 08, 2026

    Abbott Urges Ill. Jury To Reject Claims Formula Led To NEC

    Counsel for Abbott Laboratories told an Illinois jury Wednesday that four infants, whose mothers allege the company's preterm baby formula caused their serious intestinal illness, would have developed the disease "even without a drop of formula" given other risk factors and that the absence of other feeding options at the time of the babies' births dooms their parents' claims.

  • April 08, 2026

    ERISA Recap: 6 Noteworthy Decisions From March

    JPMorgan Chase & Co. narrowed but couldn't escape a suit from workers who said their health plan paid too much for prescription drugs, Genworth Financial Inc. unwound a class at the Fourth Circuit, and the Sixth Circuit breathed new life into proposed class actions against FedEx and Kellogg. Here, Law360 looks at these and three other notable decisions from March in ERISA cases.

  • April 08, 2026

    Pa. Panel Splits Bellwether Pediatrician Sex Abuse Trial

    A Pennsylvania appeals court has reversed an order consolidating four civil cases against a hospital and pediatrics association related to sexual abuse allegations against a now-incarcerated doctor, saying putting the four cases together in one trial would prejudice the defendants and likely confuse the jury.

  • April 08, 2026

    Biopharma-Focused Jeito Wraps 2nd Fund With $1.2B In Tow

    Biopharmaceutical-focused private equity shop Jeito Capital, advised by Goodwin Procter LLP, on Wednesday announced that it closed its second fund above target after raising more than €1 billion ($1.2 billion) from investors.

  • April 08, 2026

    $37M Award For Whistleblowers Nixed In Medicaid Fraud Row

    A Texas state appeals court did away with an order awarding three whistleblowers a $37 million share of the state's settlement resolving Medicaid fraud allegations against Xerox, finding their respective cases over the alleged scheme were based on publicly available information.

  • April 08, 2026

    Whistleblower, Healthcare Operator End Retaliation Suit

    A nursing home administrator who participated in a U.S. Department of Housing and Urban Development whistleblower investigation into alleged false payment claims and a healthcare facility operator agreed to end a lawsuit over his firing, according to a stipulation filed in Colorado federal court Wednesday.

  • April 08, 2026

    FedEx Says NY Attys And Medical Providers Staged Crashes

    FedEx accused a network of lawyers, medical providers and clinics of orchestrating an insurance scam in which they staged motor vehicle accidents in order to defraud the delivery giant through sham lawsuits and inflated medical bills, according to a suit filed in New York federal court.

  • April 08, 2026

    Faegre Drinker Hires 2 Venable FDA Partners In DC

    Faegre Drinker Biddle & Reath LLP has hired two attorneys from Venable LLP who joined that firm in 2023 and focus their practices on helping clients understand U.S. Food and Drug Administration regulatory frameworks, the firm announced Wednesday.

Expert Analysis

  • 4 Trends Shaping Drug And Medical Device Law For 2026

    Author Photo

    2025 saw some significant legal developments with potential impact for drug and device manufacturers, ranging from growing skepticism in science and regulatory entities to new regulation of artificial intelligence, say attorneys at Faegre Drinker.

  • Key Trends In Healthcare Antitrust In 2025

    Author Photo

    The healthcare industry braced for significant antitrust enforcement shifts last year driven by a change in administration, and understanding the implications of these trends is critical for healthcare organizations' risk management and strategic decision-making in the year ahead, say attorneys at Michael Best.

  • The 5 Most Important Bid Protest Decisions Of 2025

    Author Photo

    In a shifting bid protest landscape, five decisions in 2025 from the Federal Circuit, the U.S. Court of Federal Claims and the U.S. Government Accountability Office that addressed bedrock questions about jurisdictional reach and the breadth of agency discretion are likely to have a lasting impact, say attorneys at Bradley Arant.

  • Food Industry Braces For MAHA And Other Challenges In 2026

    Author Photo

    After the Make America Healthy Again movement kept the U.S. Food and Drug Administration under pressure in 2025, actions in the food safety space are likely to continue this year, including updated Supplemental Nutrition Assistance Program dietary guidelines and processed food definitions, say attorneys at Wiley.

  • Preparing For Congressional Investigations In A Midterm Year

    Author Photo

    2026 will be a consequential year for congressional oversight as the upcoming midterm elections may yield bolder investigations and more aggressive state attorneys general coalitions, so companies should consider adopting risk management measures to get ahead of potential changes, say attorneys at Morgan Lewis.

  • A Meaningful Shift In FDA's Biosimilarity Analysis

    Author Photo

    The U.S. Food and Drug Administration's potential pivot away from routinely requiring comparative efficacy studies for interchangeable biosimilar applications would not lower regulatory standards, but instead allow applicants to allocate resources toward establishing more probative evidence, says Theodore Thompson at Stinson.

  • Employment Immigration Trends And Challenges For 2026

    Author Photo

    U.S. companies competing for global talent should brace for a turbulent 2026, with greater compliance burdens, higher costs and the probability of workforce disruptions at every stage of the immigration process, from visa petitions to work authorization renewals, say attorneys at Duane Morris.

  • Top 5 Antitrust Issues For In-House Counsel To Watch In 2026

    Author Photo

    With Trump administration enforcement policy having largely taken shape last year, antitrust issues that in-house counsel should have on the radar range from scrutiny of technology-assisted pricing to the return of merger remedies, say attorneys at Squire Patton.

  • 4 Developments That Defined The 2025 Ethics Landscape

    Author Photo

    The legal profession spent 2025 at the edge of its ethical comfort zone as courts, firms and regulators confronted how fast-moving technologies and new business models collide with long-standing professional duties, signaling that the profession is entering a period of sustained disruption that will continue into 2026, says Hilary Gerzhoy at HWG Law.

  • Navigating AI In The Legal Industry

    Author Photo

    As artificial intelligence becomes an increasingly integral part of legal practice, Law360 guest commentary this year examined evolving ethical obligations, how the plaintiffs bar is using AI to level the playing field against corporate defense teams, and the attendant risks of adoption.

  • How Fractional GCs Can Manage Risks Of Engagement

    Author Photo

    As more organizations eliminate their in-house legal departments in favor of outsourcing legal work, fractional general counsel roles offer practitioners an engaging and flexible way to practice at a high level, but they can also present legal, ethical and operational risks that must be proactively managed, say attorneys at Boies Schiller.

  • Health, Legal Employers Face Unique Online Speech Hurdles

    Author Photo

    Employers in the legal and healthcare industries must consider distinctive ethical obligations and professional requirements when disciplining employees for social media posts, while anticipating an area of the law in flux as courts seek to balance speech rights and the workplace function, say attorneys at FordHarrison.

  • Reviewing 2025's Most Pertinent Wiretap Developments

    Author Photo

    2025 was a remarkable year in the world of web tracking wiretapping litigation, not only for the increased caseload but also because of numerous developing theories of liability, with disputes expected to continue unabated in 2026, say attorneys at Squire Patton.

  • 2025 Legal Milestones That Will Shape Psychedelics Sector

    Author Photo

    As 2025 draws to a close, psychedelic drug development stands at an inflection point, experiencing unprecedented momentum through recent sweeping regulatory changes and landmark clinical milestones, amid rapidly evolving regulatory expectations, say Odette Hauke at Odette Alina LLC and Kimberly Chew at Husch Blackwell.

  • Series

    Nature Photography Makes Me A Better Lawyer

    Author Photo

    Nature photography reminds me to focus on what is in front of me and to slow down to achieve success, and, in embracing the value of viewing situations through different lenses, offers skills transferable to the practice of law, says Brian Willett at Saul Ewing.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.